These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1460211)

  • 21. Control of the hypersecretion of vasomotor rhinitis by topical ipratropium bromide.
    Dolovich J; Kennedy L; Vickerson F; Kazim F
    J Allergy Clin Immunol; 1987 Sep; 80(3 Pt 1):274-8. PubMed ID: 2957416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. OTC use of a topical nasal spray solution containing xylometazoline plus ipratropium in patients with common cold.
    Strandell B; Norgren-Holst E; Tran N; Jakobsen HB; Chen S
    Int J Clin Pharmacol Ther; 2009 Dec; 47(12):744-51. PubMed ID: 19954713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of topical combinations of ipratropium and xylometazoline for the treatment of symptoms of runny nose and nasal congestion associated with acute upper respiratory tract infection.
    Eccles R; Pedersen A; Regberg D; Tulento H; Borum P; Stjärne P
    Am J Rhinol; 2007; 21(1):40-5. PubMed ID: 17283559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intranasal ipratropium bromide for the common cold.
    Albalawi ZH; Othman SS; Alfaleh K
    Cochrane Database Syst Rev; 2011 Jul; (7):CD008231. PubMed ID: 21735425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A clinical trial of ipratropium bromide nasal spray in patients with perennial nonallergic rhinitis.
    Bronsky EA; Druce H; Findlay SR; Hampel FC; Kaiser H; Ratner P; Valentine MD; Wood CC
    J Allergy Clin Immunol; 1995 May; 95(5 Pt 2):1117-22. PubMed ID: 7751528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of terfenadine and ipratropium bromide alone and in combination on bradykinin-induced nasal symptoms and plasma protein leakage.
    Rajakulasingam K; Polosa R; Lau LC; Church MK; Holgate ST; Howarth PH
    Clin Exp Allergy; 1992 Jul; 22(7):717-23. PubMed ID: 1387041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ipratropium bromide treatment of experimental rhinovirus infection.
    Gaffey MJ; Hayden FG; Boyd JC; Gwaltney JM
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1644-7. PubMed ID: 2855297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold.
    Eccles R; Martensson K; Chen SC
    Curr Med Res Opin; 2010 Apr; 26(4):889-99. PubMed ID: 20151787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Product characteristics and pharmacokinetics of intranasal ipratropium bromide.
    Wood CC; Fireman P; Grossman J; Wecker M; MacGregor T
    J Allergy Clin Immunol; 1995 May; 95(5 Pt 2):1111-6. PubMed ID: 7751527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Common cold and high-dose ipratropium bromide: use of anticholinergic medication as an indicator of reflex-mediated hypersecretion.
    Ostberg B; Winther B; Borum P; Mygind N
    Rhinology; 1997 Jun; 35(2):58-62. PubMed ID: 9299652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intranasal ipratropium bromide for the common cold.
    AlBalawi ZH; Othman SS; Alfaleh K
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD008231. PubMed ID: 23784858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of ipratropium bromide on nasal hypersecretion induced by methacholine in patients with vasomotor rhinitis. A double-blind, cross-over, placebo-controlled and randomized dose-response study.
    Sjögren I; Jonsson L; Köling A; Jansson C; Osterman K; Håkansson B
    Acta Otolaryngol; 1988; 106(5-6):453-9. PubMed ID: 2974675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of ipratropium bromide 0.03% with beclomethasone dipropionate in the treatment of perennial rhinitis in children.
    Milgrom H; Biondi R; Georgitis JW; Meltzer EO; Munk ZM; Drda K; Wood CC
    Ann Allergy Asthma Immunol; 1999 Aug; 83(2):105-11. PubMed ID: 10480582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of single and multiple doses of pseudoephedrine in the treatment of nasal congestion associated with common cold.
    Eccles R; Jawad MS; Jawad SS; Angello JT; Druce HM
    Am J Rhinol; 2005; 19(1):25-31. PubMed ID: 15794071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. A randomized, double-blind, placebo-controlled trial.
    Prasad AS; Fitzgerald JT; Bao B; Beck FW; Chandrasekar PH
    Ann Intern Med; 2000 Aug; 133(4):245-52. PubMed ID: 10929163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: the ICICC trial.
    Eccles R; Winther B; Johnston SL; Robinson P; Trampisch M; Koelsch S
    Respir Res; 2015 Oct; 16():121. PubMed ID: 26438038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical, double-blind, placebo-controlled study investigating the combination of acetylsalicylic acid and pseudoephedrine for the symptomatic treatment of nasal congestion associated with common cold.
    Loose I; Winkel M
    Arzneimittelforschung; 2004; 54(9):513-21. PubMed ID: 15500197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized controlled trial of clemastine fumarate for treatment of experimental rhinovirus colds.
    Gwaltney JM; Park J; Paul RA; Edelman DA; O'Connor RR; Turner RB
    Clin Infect Dis; 1996 Apr; 22(4):656-62. PubMed ID: 8729205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cold-induced rhinitis in skiers--clinical aspects and treatment with ipratropium bromide nasal spray: a randomized controlled trial.
    Bonadonna P; Senna G; Zanon P; Cocco G; Dorizzi R; Gani F; Landi M; Restuccia M; Feliciello A; Passalacqua G
    Am J Rhinol; 2001; 15(5):297-301. PubMed ID: 11732814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical device in children with acute symptoms of common cold.
    Fazekas T; Eickhoff P; Pruckner N; Vollnhofer G; Fischmeister G; Diakos C; Rauch M; Verdianz M; Zoubek A; Gadner H; Lion T
    BMC Complement Altern Med; 2012 Sep; 12():147. PubMed ID: 22950667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.